List of Biotech ETFs Listed on U.S. Exchanges

The number of ETFs focusing on the biotech industry has increased in recent years giving investors more options in specialized biotech ETFs. These specialized ETFs focus on companies who have products in a particular phase of the Food and Drug Administration trial process. These ETFs join a group of ETFs that traditionally have focused on the largest companies in the biotechnology industry. Examples of these large-cap companies that are in many of this ETFs include:

Amgen Inc. (AMGN)

Biogen Inc. (BIIB)

Celgene Corporation (CELG)

Gilead Sciences, Inc. (GILD)

Biotech ETFs

ALPS Medical Breakthroughs ETF (SBIO) (At least one drug in either a phase II or phase III FDA clinical trial)

BioShares Biotechnology Clinical Trials ETF (BBC) (Primary product offering in Phase 1, Phase 2 and/or Phase 3 of the clinical trial stage)

BioShares Biotechnology Products ETF (BBP) (At least one candidate that has received U.S. Food and Drug Administration approval)

First Trust NYSE Arca Biotechnology Index Fund (FBT) (Biotech companies that use biological processes to develop products or provide services)

iShares Nasdaq Biotechnology ETF (IBB) (Weighted towards larger-sized biotech companies)

Market Vectors Biotech ETF (BBH) (Weighted towards larger-sized biotech companies)

PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) (Large, mid and small-sized biotech companies; weighted towards larger-sized biotech companies)

SPDR Biotech ETF (XBI) (Based on S&P Biotechnology Select Industry Index)

Biotech: Leveraged

Direxion Daily S&P Biotech Bull 3X Shares (LABU)

ProShares Ultra Nasdaq Biotechnology (BIB)

Proshares UltraPro Nasdaq Biotechnology (UBIO)

Biotech: Short

Direxion Daily S&P Biotech Bear 3X Shares (LABD)

ProShares UltraPro Short NASDAQ Biotechnology (ZBIO)

ProShares UltraShort Nasdaq Biotechnology (BIS)